Compare PBLS & ANDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBLS | ANDG |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.1B |
| IPO Year | 2026 | 2025 |
| Metric | PBLS | ANDG |
|---|---|---|
| Price | $25.11 | $58.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | $41.75 | ★ $59.86 |
| AVG Volume (30 Days) | ★ 910.8K | 420.0K |
| Earning Date | 11-17-2026 | 11-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $838,692,000.00 |
| Revenue This Year | N/A | $18.38 |
| Revenue Next Year | $222.58 | $18.35 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 14.64 |
| 52 Week Low | $22.78 | $18.12 |
| 52 Week High | $42.49 | $60.16 |
| Indicator | PBLS | ANDG |
|---|---|---|
| Relative Strength Index (RSI) | 36.35 | 63.28 |
| Support Level | N/A | $52.10 |
| Resistance Level | $41.72 | N/A |
| Average True Range (ATR) | 2.31 | 2.03 |
| MACD | -0.41 | 0.19 |
| Stochastic Oscillator | 28.27 | 88.24 |
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.
Andersen Group Inc is a provider of independent tax, valuation, and financial advisory services to individuals and family offices, businesses, and institutional clients in the United States. It has strategically expanded its business to build an integrated platform of service offerings that enables the company to solve its clients' complex tax and financial challenges. The company's end-to-end services offerings include: Private Client Services, Business Tax Services, Alternative Investment Funds, and Valuation Services. The firm generates the key revenue from Private Client Services, which provide comprehensive tax and financial services for individuals and families, addressing complex client matters involving multigenerational wealth, charitable giving, and trust and estate planning.